ATOVAQUONE AND PROGUANIL HYDROCH. Key specifications include part_name_assigned_by_controlling_agency: ATOVAQUONE 250MG AND PROGUANIL 100MG TABLETS BT 100'S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-491-9430, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
WHERE IT FITS
01-0583
NSN:6505-01-491-9430 FSC:6505 — Drugs and Biologicals CAGE:89875 — DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA (USA)
SPECIFICATIONS
part_name_assigned_by_controlling_agency
ATOVAQUONE 250MG AND PROGUANIL 100MG TABLETS BT 100'S
NSN
6505-01-491-9430
COMPONENT DIAGRAM
TECHNICAL CHARACTERISTICS
SPECIAL FEATURES
MALARONE CONTAINS ATOVAQUONE 250 MG AND PROGUANIL HYDROCHLORIDE 100MG; ADMINISTRATION ORAL;CHILD RESISTANT CLOSURE; MALARONE IS INDICATED FOR THE TREATMENT OF ACUTE, UNCOMPLICATED P. FALCIPARUM MALARIA; STORE AT 25 DEGREES C (77 DEGREES F)
PART NAME ASSIGNED BY CONTROLLING AGENCY
ATOVAQUONE 250MG AND PROGUANIL 100MG TABLETS BT 100'S
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 01-0583?
01-0583 is a ATOVAQUONE AND PROGUANIL HYDROCH manufactured by Legrand.
What parts can replace 01-0583?
There are 3 known substitutes for 01-0583: MALARONE, NDC66993-0060-02, NDC51407-0869-01. Substitute compatibility should be verified for your specific system.
What is the NSN for 01-0583?
01-0583 is cataloged in the U.S. Government catalog under NSN 6505-01-491-9430. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.